The unique upregulation of the eosinophil-specific chemoattractant, CCL11, suggests the potential activation of an eosinophil-mediated inflammatory response, which can be one of the mechanisms contributing to myocardial injury and heart failure in COVID-19 patients (63). Here, CCL11 is linked to heart failure.